The Future Is Healthcare

Healthcare is not simply another sector of the economy. With an aging US population and risks to federal funding, healthcare is likely to be both a major factor during the 2030s depression and a driving force for future economic opportunities.

Healthcare demand is increasingly driven by structural forces that are difficult to reverse. We can expect long-term momentum will be propped up by factors such as:

• Demographic aging
• Growing prevalence and burden of chronic conditions
• Advances in medical technology
• Growing expectations for quality of care

All in all, demand for healthcare is challenging the limits of what the economy and science can deliver.

For businesses, the question is not whether healthcare spending will continue to rise, but where the greatest opportunities will emerge and how to manage the risks associated with likely regulatory hurdles and potential shortfalls in federal funding.

Healthcare Spending Data

The numbers tell a story that is impossible to ignore.

Total US healthcare spending from both public and private funds reached approximately $5.3 trillion – roughly $15,500 per person – in 2024. This represents a whopping 18% of US GDP.

In June 2026, inflation-adjusted Personal Consumption Expenditures for Healthcare were 39.7% above where they were 10 years ago. While some of these higher costs may have been absorbed by insurance companies or federal funding, a substantial portion is coming out of consumers’ pockets.

Healthcare is consuming a growing share of both household budgets and the broader economy, and there is little evidence that these long-term trends are reversing.

Chronic Disease and Innovation

Healthcare demand is increasing not only as the population ages, but also because a greater number of young Americans are living with diagnosed diseases that require ongoing management. This shift is attributable to disease trends (such as increased prevalence of obesity and depression), improved detection rates, and longer survival for certain conditions.

According to the Centers for Disease Control and Prevention, approximately 90% of US annual healthcare expenditures go toward treating chronic conditions. Rather than simply providing episodic, life-saving care, providers are increasingly managing patients over many years. Consequently, demand for quality-of-life products – whether it be medications, mobility aids, or gadgets that monitor vitals and manage pain – is likely to strengthen.

Chronic conditions are driving some innovations in healthcare. New biologic therapies, cell and gene therapies, immunotherapies, precision medicine, and GLP-1 medications are transforming treatment options for diseases that were previously only managed through symptom control.

Healthcare technology companies are improving efficiency through artificial intelligence and automation. Medical device manufacturers continue to introduce less-invasive procedures. Diagnostic companies are expanding access to earlier detection. Even industries typically removed from traditional healthcare may find opportunities related to the health economy.

Many Recession Resistant Markets Are Health-Related

We have done a deep dive into historical data to determine which markets are typically more resistant to recession. Interestingly, many of the markets we identified were healthcare related, including hospitals, home health products, medical tech support, and both prescription and over-the-counter drugs.

This suggests healthcare markets are a great diversification strategy for businesses, but it does not mean healthcare markets are without risk.

• Hospitals are facing higher risks of bad debts as costs rise amid expectations for higher-quality care and spotty Medicaid and insurance coverage.
• Strain on federal budgets and shortfalls in Social Security funding are likely to cause disruptions.
• As new online and tech-enabled healthcare platforms open, there is also a risk that regulatory frameworks will evolve in ways that eat into margins.

Opening your business up to healthcare exposure should go hand-in-hand with robust diversification and regulatory risk management strategies.

Looking Beyond Hospitals

A healthcare-focused future will impact far more than just hospitals. We can expect higher demand for medical devices, diagnostics, pharmaceuticals, biotechnology, outpatient services, senior housing, home health, digital health platforms, and healthcare staffing.

The healthcare industry will undoubtedly face policy debates, reimbursement changes, labor shortages, and regulatory challenges. Those issues will create winners and losers within the sector.

The broader trend, however, appears remarkably durable.